EFFECT OF FLAG REGIMEN IN TREATMENT OF CHILDREN WITH ACUTE REFRACTORY AND RELAPSED LEUKEMIA

被引：0
|
作者：
Lin, Y. [1 ]
机构：
[1] Guangdong Gen Hosp, Guangdong Acad Med Sci, Dept Pediat Hematol Oncol, Guangzhou, Guangdong, Peoples R China
来源：
PEDIATRIC BLOOD & CANCER | 2013年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：213 / 213
页数：1
相关论文
共 50 条
  • [21] FLAG-IDA IN THE TREATMENT OF REFRACTORY/RELAPSED ACUTE LEUKEMIA: A SINGLE CENTRE EXPERIENCE
    Delia, M.
    Pastore, D.
    Carluccio, P.
    Ricco, A.
    Manduzio, P.
    Ingrosso, C.
    Sgherza, N.
    Fesce, V.
    Mongelli, P.
    Giannoccaro, M.
    Angarano, R.
    Longo, M. C.
    Mazzone, A.
    Liso, V.
    Specchia, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 555 - 555
  • [22] FLAG-IDA in the treatment of refractory/relapsed acute leukemia: A single institutional study
    Carluccio, P.
    Pastore, D.
    Pannunzio, A.
    Rossi, A.
    Lerario, P.
    Spinosa, G.
    Giannoccaro, M.
    Mazzone, A. M.
    Santodirocco, M.
    Fesce, V.
    Lubelli, C.
    Liso, A.
    Liso, V.
    Specchia, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 396 - 396
  • [23] FLAG/FLAG-Ida Regimen in Secondary and Relapsed/Refractory Acute Myeloid Leukemia-Even in the Era of New Treatment Modalities Still a Significant Player
    Doma, Sasa Anzej
    Sever, Matjaz
    Jakos, Gorazd
    Podgornik, Helena
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (07)
  • [24] Gemtuzumab ozogamicin with FLAG-IDA is effective for children in relapsed/refractory acute myeloid leukemia.
    Cho, Bin
    Kim, Sun Young
    Lee, Dae Hyoung
    Kwon, Young Joo
    Park, Young Shil
    Hwang, Hui Sung
    Park, Ji Kyoung
    Jang, Pil Sang
    Chung, Nak Gyun
    Jeong, Dae-Chul
    Kim, Hack Ki
    BLOOD, 2006, 108 (11) : 218B - 218B
  • [25] Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia
    Paul, Shilpa
    Rausch, Caitlin R.
    Nasnas, Patrice E.
    Kantarjian, Hagop
    Jabbour, Elias J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (03) : 166 - 175
  • [26] Treatment of relapsed or refractory acute promyelocytic leukemia
    Tallman, Martin S.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (01) : 57 - 65
  • [27] Treatment for Relapsed/Refractory Acute Myeloid Leukemia
    Thol, Felicitas
    Heuser, Michael
    HEMASPHERE, 2021, 5 (06): : E572
  • [28] Treatment of relapsed and refractory acute myelogenous leukemia
    Estey, EH
    LEUKEMIA, 2000, 14 (03) : 476 - 479
  • [29] Treatment of Relapsed/Refractory Acute Myeloid Leukemia
    Bose, Prithviraj
    Vachhani, Pankit
    Cortes, Jorge E.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (03)
  • [30] Treatment of Relapsed/Refractory Acute Myeloid Leukemia
    Prithviraj Bose
    Pankit Vachhani
    Jorge E. Cortes
    Current Treatment Options in Oncology, 2017, 18
12345